Browse

S-Space

Browsing by Author 3321

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 60 of 277

Issue Date Title / Author(s) / CitationFile
1999
Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma
DOI
2002
Colorectal cancer in Korea: characteristics and trends

Kim, Dong-Wan; Bang, Yung-Jue; Heo, Dae Seog; Kim, Noe Kyeong

Tumori, Vol.88 No.4, pp.262-265

DOI
2003
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients - Comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage
DOI
2003
Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: Methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone
DOI
2004
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies
DOI
2004
Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients

Lee, June-Chul; Lee, Kyung-Mi; Kim, Dong-Wan; Heo, Dae Seog

Journal of Immunology, Vol.172 No.12, pp.7335-7340

DOI
2004
Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy
DOI
2004
A multi-center, late phase II clinical trial of Genexol (R) (paclitaxel) and cisplatin for patients with advanced gastric cancer
DOI
2004
Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma
DOI
2005
Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer
link
2005
Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa (R), ZD1839) in chemotherapy-resistant non-small cell lung cancer
link
2005
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib
DOI
2005
Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer
DOI
2005
Docetaxel+5-fluorouracil plus cisplatin 3-day combination chemotherapy as a first-line treatment in patient with unresectable gastric cancer
link
2005
Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer
view fileDOI
2005
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer
link
2005
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I-E/IIE extranodal NK/T-cell lymphoma, nasal type
link
2006
CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience
link
2006
Antibiotic use during the last days of life in cancer patients
DOI
2006
Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation
DOI
2006
Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer
link
2006
High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy
link
2006
Primary systemic anaplastic large cell lymphoma in a single Korean institution: Clinical characteristics and treatment outcome
view filelink
2006
Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients
DOI
2007
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
view fileDOI
2007
Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer
DOI
2007
Artificial nutrition and hydration in terminal cancer patients: the real and the ideal
link
2007
Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer
view filelink
2007
Palliative chemotherapy for pulmonary pleomorphic carcinoma
DOI
2007
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
view filelink
2007
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
link
2008
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer
link
2008
Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma
link
2008
Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer
DOI
2008
Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer
link
2008
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer
link
2008
A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker
DOI
2008
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker
view filelink
2008
Aggressiveness of cancer-care near the end-of-life in Korea

Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Mi Ra; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Heo, Dae Seog

Japanese Journal of Clinical Oncology, Vol.38 No.5, pp.381-386

link
2008
ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
DOI
2008
Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment
DOI
2008
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives
link
2008
Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
view filelink
2008
Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients
DOI
2009
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone
DOI
2009
Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival
DOI
2009
The role of PET/CT in detection of gastric cancer recurrence
view fileDOI
2009
Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: A retrospective analysis
view fileDOI
2009
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI
DOI
2009
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy
link
2009
Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma
DOI
2009
Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin
DOI
2009
Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma
DOI
2009
Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer
link
2009
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement
DOI
2009
Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma
DOI
2009
Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and beta III-Tubulin Between Primary Non-small Cell Lung Cancer and Metastatic Lymph Nodes and the Significance in Mid-Term Survival
DOI
2009
Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy
view fileDOI
2010
Timing of local and distant failure in resected lung cancer: Implications for reported rates of local failure

Boyd, Jessamy A.; Hubbs, Jessica L.; Kim, Dong-Wan; Hollis, Donna; Marks, Lawrence B.; Kelsey, Chris R.

Journal of Thoracic Oncology, Vol.5 No.2, pp.211-214

DOI
2010
Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer
DOI
1 2 3 4 5
RSS 1.0 RSS 2.0 Atom

Seoul National University Library, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea TEL: 02-880-5567 Email: s-space@snu.ac.kr

Hello

Browse

News About S-Space Seoul National University Library LOGIN